分享好友 资讯首页 频道列表

2012年吉林省卫生厅疫苗(第二次)项目成交结果公告

2012-11-22 09:03806740
1.项目名称:吉林省卫生厅疫苗(第二次)项目;项目简要情况: 第一包冻干甲型肝炎减毒活疫苗18.28万剂;第三包口服脊髓灰质炎减毒活疫苗50.04万剂;第五包A群C群脑膜炎球菌多糖疫苗41.7万剂,交货时间:合同订立后3天用于卫生防疫使用。

2.采购文件编号:JLZC2012-0273(2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

3.第二次发布招标公告的日期:2012年8月30日

吉林省政府采购中心于2012年10月12日就本项目进行第二次公开招标,第一包、第三包因只有一个投标人而废标。因采购单位需求紧急,经采购单位请示吉林省财政厅政府采购办批准,变更为与第一包、第三包的唯一投标人进行单一来源谈判方式采购,由采购单位按照批准的采购方式进行了采购。

4.第一包成交供应商名称:长春长生生物科技股份有限公司

第一包成交供应商地址:长春市高新区越达路1615号

第一包成交金额:3,528,040.00元

第三包成交供应商名称:北京天坛生物制品股份有限公司

第三包成交供应商地址:长春市高新区越达路1615号

第三包成交金额:265,212.00元

第五包中标供应商名称:兰州生物制品研究所有限责任公司

第五包中标供应商地址:兰州市盐场路888号

第五包中标金额: 1,459,500.00元

5.第一包、第三包定标日期:2012年11月20日

第五包定标日期:2012年10月12日

6.采购人名称:吉林省卫生厅

地  址:长春市人民大街1485号

联系人:李怀忠

联系电话:0431-88905197

7.吉林省政府采购中心

地址:吉林省长春市文化街158号

联系人:周君

联系电话:0431-88904932                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

反对 0
举报 0
收藏 0
打赏 0
评论 0
福安药业:子公司庆余堂注射用赖氨匹林获批
9 月 11 日,福安药业 (300194.SZ) 发布公告,公司全资子公司福安药业集团庆余堂制药有限公司收到国家药监局核发的注射用赖氨

0评论2026-09-1510

最高28.75亿美元!礼来收购Merida加码免疫疾病赛道
当地时间周一,美国医药巨头礼来公司宣布,已与生物科技企业 Merida Biosciences 达成最终收购协议,最高斥资 28.75 亿美元现金

0评论2026-09-0161

这家山东药企开挂了!净利润暴增182%,1类新药大涨74%,新品进军360亿新市场
日前,罗欣药业公布2026年上半年业绩,报告期内公司业绩双增,其中归母净利润同比大涨182.19%。已上市1类新药保持快速且持续放量

0评论2026-08-2896

狂涨139%,石药集团翻盘了
在创新药及BD收入增量贡献下,石药集团业绩翻盘了。创新药、海外BD发力!净利润暴涨139%受集采、医保控费等因素影响,近年来石药

0评论2026-08-24103

福元医药亮了!斩获79个重磅品种、94个过评产品,14个品种冲刺新国采,1类新药瞄准1200亿市场
日前,福元医药2款产品糠酸莫米松乳膏(10g:10mg)、联苯苄唑溶液(30ml:0.3g)新增品规的补充申请获批,公司14个品种拟参与第十

0评论2026-07-27157

科技向善,惠及患者:诺和诺德以 AI 重塑专业能力培养体系,斩获全球绩效改进大奖
在生命科学与医疗健康产业中,医学信息的传递不止是普通的商业沟通,更是关乎患者生命质量与公共卫生的核心枢纽。对于深耕中国三

0评论2026-06-16230

人福医药火力全开!中枢神经药物大卖92亿,40多款新药攻势凌厉,15个亿级产品曝光
神经系统药物龙头集团人福医药发布了2025年业绩,营业收入稳坐200亿梯队,净利润大涨39.53%,超过18亿元。近期,集团成功拿下了

0评论2026-04-16330